Humanizing mice for the identification of novel anticancer lipids targeting iNKT cells.

Humanizing mice for the identification of novel anticancer lipids targeting iNKT cells.
复制标题

DOI:
10.4161/onci.25475
复制
发表时间:
2013-08-01
期刊:
影响因子:
7.2
通讯作者:
Yuan W
Yuan W
中科院分区:
医学2区
文献类型:
--
作者:
Wen X;Xiong R;Dai Z;Kim S;Lawrenczyk A;Yuan W

文献摘要

参考文献

相似文献

CD 1d依赖性脂质抗原呈递给自然杀伤T(NKT)细胞是先天免疫系统的组成部分。然而,迄今为止,基于NKT细胞激动剂的抗癌疗法的开发取得了有限的成功。人源化小鼠的CD 1d/NKT抗原呈递系统将提供一种工具,以确定新的脂质,发挥靶向NKT细胞之前的昂贵和漫长的临床试验的抗肿瘤功能。
The CD1d-dependent presentation of lipid antigens to natural killer T (NKT) cells is an integral part of the innate immune system. However, the development of anticancer therapies based on NKT-cell agonists has had limited success so far. Humanizing mice with respect to the CD1d/NKT antigen presentation system will provide a tool to identify novel lipids that exert antineoplastic functions by targeting NKT cells before the initiation of costly and lengthy clinical trials.
DOI: 10.1039/c0ob00975j
发表时间: 2011-01-01
影响因子: 3.2
作者:
Banchet-Cadeddu, Aline;Henon, Eric;Haudrechy, Arnaud
通讯作者: Haudrechy, Arnaud
DOI: 10.1038/ni1225
发表时间: 2005-08-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Koch, M;Stronge, VS;Cerundolo, V
通讯作者: Cerundolo, V
NIK依赖性RELB激活定义了V alpha 14i NKT细胞开发的独特信号通路。
DOI: 10.1084/jem.20030141
发表时间: 2003-06-16
期刊: The Journal of experimental medicine
影响因子: --
作者:
Elewaut D;Shaikh RB;Hammond KJ;De Winter H;Leishman AJ;Sidobre S;Turovskaya O;Prigozy TI;Ma L;Banks TA;Lo D;Ware CF;Cheroutre H;Kronenberg M
通讯作者: Kronenberg M
DOI: 10.1016/j.immuni.2009.03.022
发表时间: 2009-06-19
期刊: IMMUNITY
影响因子: 32.4
作者:
Im, Jin S.;Arora, Pooja;Bricard, Gabriel;Molano, Alberto;Venkataswamy, Manjunatha M.;Baine, Ian;Jerud, Elliot S.;Goldberg, Michael F.;Baena, Andres;Yu, Karl O. A.;Ndonye, Rachel M.;Howell, Amy R.;Yuan, Weiming;Cresswell, Peter;Chang, Young-tae;Illarionov, Petr A.;Besra, Gurdyal S.;Porcelli, Steven A.
通讯作者: Porcelli, Steven A.
DOI: 10.4049/jimmunol.170.5.2390
发表时间: 2003-03-01
影响因子: 4.4
作者:
Capone, M;Cantarella, D;Casorati, G
通讯作者: Casorati, G